| Literature DB >> 25947010 |
Andreas Meyer1, Sabine Günther2, Timm Volmer3, Karin Taube4, Hans J Baumann5.
Abstract
BACKGROUND: Physical training has been shown to improve exercise capabilities in patients with asthma. Most studies focused on children and younger adults. Previously, the maximum program duration was six months. It is not known whether the same results may be obtained with lower intensity programs and sustained for time periods longer than 6 months. This controlled study was undertaken to investigate the effects of a moderate intensity outpatient training program of one year duration on physical fitness and quality of life in adults with asthma.Entities:
Mesh:
Year: 2015 PMID: 25947010 PMCID: PMC4431028 DOI: 10.1186/s12890-015-0053-8
Source DB: PubMed Journal: BMC Pulm Med ISSN: 1471-2466 Impact factor: 3.317
Figure 1Study design (according to the CONSORT statement).
Baseline characteristics of the study population (n = 21)
|
|
|
| |
|---|---|---|---|
| Number | 13 | 8 | n.s. |
| Sex (F/M) | 8/5 | 5/3 | n.s. |
| Age (years) | 54 ± 11 | 59 ± 9 | n.s. |
| Duration of disease (years) | 19 ± 22 | 21 ± 15 | n.s. |
| Allergic asthma | 5/13 | 4/8 | n.s. |
| Body mass index (kg/m2) | 23 ± 1.6 | 22 ± 2.1 | n.s. |
| VC (L) | 3.4 ± 0.9 | 3.0 ± 0.8 | n.s. |
| FVC (L) | 3.3 ± 0.9 | 3.0 ± 1.0 | n.s. |
| VC %pred | 89 ± 14% | 80 ± 14% | n.s. |
| FEV1 (L) | 2.2 ± 0.8 | 2.0 ± 0.7 | n.s. |
| FEV1 %pred | 74 ± 24% | 67 ± 16% | n.s. |
| FEV1 / FVC (%) | 0.66 ± 0.092 | 0.66 ± 0.085 | n.s. |
| Medication | n.s. | ||
| ICS (mg/d) | 0.85 ± 0.4 | 0.8 ± 0.4 | n.s. |
| long acting beta agonist | 6/13 | 3/8 | n.s. |
| montelukast | 2/13 | 1/8 | n.s. |
Values are mean ± standard deviation.
F: female.
FEV1: forced expiratory volume in one second in litre/% of predicted.
ICS: inhaled corticosteroids (relative to beclomethasone).
M: male.
n.s.: not significant.
OC: intermittent use of oral corticosteroids during the study period.
VC: vital capacity.
Peak exercise tolerance of training and control group before (t1) and after (t2) one year
|
|
| |||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
|
|
|
|
|
|
| |
| WR (Watt) ∑ | 97 ± 32 | 116 ± 31 | 0.005 | 107 ± 22 | 100 ± 28 | 0.480 |
| VO2 (ml/kg/min) + | 15.7 ± 5.0 | 20.4 ± 4.0 | 0.004 | 15.8 ± 4.0 | 16.8 ± 6.2 | 0.452 |
| VO2/HR (ml) | 8.7 ± 3.6 | 12.2 ± 3.9 | 0.032 | 9.4 ± 2.7 | 11.0 ± 2.5 | 0.108 |
| VE (l/min) + | 38.2 ± 17.3 | 51.5 ± 20.3 | 0.002 | 42.1 ± 10.0 | 42.1 ± 10.3 | 0.993 |
Values are mean ± standard deviation.
No statistically significant differences between both groups at t1.
∑ p < 0.05 between both groups at t2.
n.s.: not significant.
VO2/HR: O2pulse.
VE: minute ventilation.
VO2: oxygen uptake per kg body weight.
WR: work rate.
+ p < 0.1 between both groups at t2.
Health-related quality of life of training and control group before (t1) and after (t2) one year
|
|
| |||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
| Physical functioning | 62 ± 26 | 71 ± 20 | 0.016 | 69 ± 21 | 66 ± 28 | 0.752 |
| Social functioning | 67 ± 26 | 79 ± 22 | 0.014 | 67 ± 27 | 73 ± 22 | 0.703 |
| Role limitations: Physical | 23 ± 23 | 31 ± 18 | 0.256 | 14 ± 20 | 21 ± 22 | 0.200 |
| Role limitations: Emotional | 48 ± 44 | 58 ± 47 | 0.515 | 38 ± 38 | 62 ± 45 | 0.172 |
| Mental health | 55 ± 21 | 64 ± 13 | 0.119 | 56 ± 14 | 63 ± 23 | 0.270 |
| Energy/vitality | 46 ± 25 | 54 ± 18 | 0.418 | 41 ± 15 | 54 ± 24 | 0.140 |
| Pain | 70 ± 28 | 86 ± 17 | 0.129 | 79 ± 35 | 64 ± 29 | 0.230 |
| General health perspective | 47 ± 20 | 50 ± 16 | 0.650 | 44 ± 21 | 49 ± 28 | 0.288 |
|
| ||||||
| Overall QOL | 4.3 ± 1.2 | 5.0 ± 1.1 | 0.027 | 4.3 ± 1.1 | 4.8 ± 1.5 | 0.270 |
| Activities | 4.0 ± 1.4 | 4.8 ± 1.3 | 0.009 | 3.9 ± 1.1 | 4.2 ± 1.7 | 0.691 |
| Symptoms | 4.2 ± 1.2 | 5.0 ± 1.1 | 0.093 | 4.4 ± 1.2 | 4.9 ± 1.5 | 0.222 |
| Emotions | 4.8 ± 1.8 | 5.6 ± 1.4 | 0.047 | 4.7 ± 1.3 | 5.3 ± 1.6 | 0.1 |
| Environment | 4.6 ± 1.4 | 5.1 ± 1.4 | 0.187 | 4.6 ± 1.6 | 5.2 ± 1.7 | 0.416 |
Values are mean ± standard deviation.
No statistically significant differences between both groups at t1.
AQLQ: Asthma Quality of Life Questionnaire, n.s.: not significant.
QOL: Quality of life, SF-36: Short form-36 questionnaire.